Rethinking prognostic factors in locally advanced or metastatic urothelial carcinoma in the immune checkpoint blockade era: a multicenter retrospective study

por Ruiz-Bañobre, J., Molina-Díaz, A., Fernández-Calvo, O., Fernández-Núñez, N., Medina-Colmenero, A., Santomé, L., Lázaro-Quintela, M., Mateos-González, M., García-Cid, N., López-López, R., Vázquez, S., Anido-Herranz, U.
Publicado 2021

Clinical, molecular, and immune correlates of the Immunotherapy Response Score in patients with advanced urothelial carcinoma under atezolizumab monotherapy: analysis of the phase...

por Ferreiro-Pantín, M., Anido-Herranz, U., Betancor, Y.Z., Cebey-López, V., León-Mateos, L., García-González, J., García-Acuña, S.M., Fernández-Díaz, N., Tubio, J.M.C., López-López, R., Ruiz-Bañobre, J.
Publicado 2023